Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver
Jan P. Nicolay, Jana D. Albrecht, Silvia Alberti Violetti, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1660-1671
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Therapeutic targeting of regulatory T cells in cancer
Feng Shan, Ashwin Somasundaram, Tullia C. Bruno, et al.
Trends in cancer (2022) Vol. 8, Iss. 11, pp. 944-961
Open Access | Times Cited: 115
Immunotherapy of Cancer by Targeting Regulatory T cells
Bo-Jin Chen, Jingwen Zhao, Dahong Zhang, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108469-108469
Open Access | Times Cited: 76
Chemokine Receptor-Targeted Therapies: Special Case for CCR8
Bernhard Moser
Cancers (2022) Vol. 14, Iss. 3, pp. 511-511
Open Access | Times Cited: 26
Target tumor microenvironment by innate T cells
Yan-Ruide Li, Matthew Wilson, Lili Yang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Unveiling the Role of the Cellular Tumor Microenvironment and the Therapeutic Targets it Provides in Cutaneous T-Cell Lymphoma
Nikolaos A. Chinas, Stella Kaliampou, Vasiliki Nikolaou
Current Oncology Reports (2025)
Open Access
Current state of CAR-T therapy for T-cell malignancies
Liangkui Luo, Xuan Zhou, Lijuan Zhou, et al.
Therapeutic Advances in Hematology (2022) Vol. 13
Open Access | Times Cited: 21
Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging
Brian Effer, Isabela Perez, Daniel Ulloa, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2086-2086
Open Access | Times Cited: 11
Praxisempfehlungen für die Therapie und Überwachung von Mogamulizumab‐Patienten in Deutschland
Chalid Assaf, Nina Booken, Edgar Dippel, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2025) Vol. 23, Iss. 3, pp. 341-356
Open Access
Targeting regulatory T cells in gastric cancer: Pathogenesis, immunotherapy, and prognosis
Bingyu Wang, Zaibo Zhang, Wenbo Liu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114180-114180
Open Access | Times Cited: 15
Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations
Jingjing Ren, Rihao Qu, Nur-Taz Rahman, et al.
Blood Advances (2022) Vol. 7, Iss. 3, pp. 445-457
Open Access | Times Cited: 13
Recent Emerging Immunological Treatments for Primary Brain Tumors: Focus on Chemokine-Targeting Immunotherapies
Alessio Ardizzone, Rossella Basilotta, Alessia Filippone, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 841-841
Open Access | Times Cited: 7
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
Nadia Ninosu, Susanne Melchers, Max Kappenstein, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 141-141
Open Access | Times Cited: 7
Looking ahead to targeting macrophages by CAR T- or NK-cells in blood cancers
David Kegyes, Paul Alexandru Milea, Andreea-Isabella Mazga, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 9, pp. 779-787
Closed Access | Times Cited: 2
Role of chemokines in aging and age-related diseases
Jitendra Kumar Chaudhary, Ajay Kumar Danga, A. Leela Kumari, et al.
Mechanisms of Ageing and Development (2024), pp. 112009-112009
Closed Access | Times Cited: 2
CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma
Minami Sakamoto, Tomomitsu Miyagaki, Hiroaki Kamijo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7889-7889
Open Access | Times Cited: 17
The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis
Alyxzandria M. Gaydosik, Connor J. Stonesifer, Tracy Tabib, et al.
JCI Insight (2023) Vol. 8, Iss. 19
Open Access | Times Cited: 6
Spatial Transcriptomics Analysis Reveals that CCL17 and CCL22 are Robust Indicators of a Suppressive Immune Environment in Angioimmunoblastic T Cell Lymphoma (AITL)
Jun Du, Chen Qiu, Weisong Li, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 9, pp. 270-270
Open Access | Times Cited: 8
Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches
Yuran Qiu, Weili Zhao
The Innovation Medicine (2024) Vol. 2, Iss. 1, pp. 100048-100048
Open Access | Times Cited: 1
Dynamic time warp of emotions in patients with cutaneous T-cell lymphoma treated with corticosteroids
Anne-Sophie C A M Koning, Rosanne Ottevanger, Maarten H. Vermeer, et al.
JAAD International (2024) Vol. 17, pp. 111-121
Open Access | Times Cited: 1
Chemokine receptor 4 expression on blood T lymphocytes predicts severity of major depressive disorder
Jana Freff, Eva C. Beins, Lisa Bröker, et al.
Journal of Affective Disorders (2022) Vol. 310, pp. 343-353
Closed Access | Times Cited: 7
Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker
Likun Cui, Liye Zhu, Jie Chen, et al.
Genes (2023) Vol. 14, Iss. 10, pp. 1961-1961
Open Access | Times Cited: 3
Malignant and Benign T Cells Constituting Cutaneous T-Cell Lymphoma
Shuichi Nakai, Eiji Kiyohara, Rei Watanabe
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12933-12933
Open Access | Times Cited: 7
New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications
Daniel E. Luna, Michi M. Shinohara
Current Hematologic Malignancy Reports (2023) Vol. 18, Iss. 3, pp. 83-88
Closed Access | Times Cited: 2
Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies
Till Braun, Alexandra Schrader
Cancers (2023) Vol. 15, Iss. 9, pp. 2532-2532
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top